Sees Q1 adjusted EBITDA $3M-$4M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TRHC:
- Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
- Medication Management Services Leader Cureatr Acquires SinfoníaRx
- Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations
- Tabula Rasa HealthCare raises Q4 cont-op revenue view to $82M-$83M